Chemical Structure : CDK9 inhibitor HS34
Catalog No.: PC-26367Not For Human Use, Lab Use Only.
CDK9 inhibitor HS34 is a potent, selective CDK9 inhibitor with IC50 of 1.4 nM (CDK9/CycT1), shows 250-fold selectivity over CDK2/CycA2.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CDK9 inhibitor HS34 is a potent, selective CDK9 inhibitor with IC50 of 1.4 nM (CDK9/CycT1), shows 250-fold selectivity over CDK2/CycA2.
HS34 shows potent and broad antiproliferative activity for MDA-MB-231 (GI50 = 0.22 μM) and 4T1 cells (GI50 = 0.53 μM).
HS34 (500 nM) inhibits CDK9 by 99.2%, demonstrating potent on-target activity.
HS34 effectively suppresses TNBC cell motility, inhibits the metastatic potential of TNBC cells.
HS34 suppresses RNAP II Ser2 phosphorylation, leading to the downregulation of short-lived survival and oncogenic proteins such as Mcl-1 and c-Myc, and consequently inducing apoptosis and blocking EMT-associated invasion.
HS34 (20 mg/kg, p.o.) demonstrated in vivo antitumor efficacy and mechanism-driven pharmacodynamics in TNBC models.
| M.Wt | 450.51 | |
| Formula | C25H27FN4O3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Huang Y, et al. J Med Chem. 2026 Mar 11. doi: 10.1021/acs.jmedchem.5c03822.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright